News

226 to 235 of 97252 results

Australian CCC grants interim authorization for Medicines Australia’s ‘transparent’ Code of Conduct

Australian CCC grants interim authorization for Medicines Australia’s ‘transparent’ Code of Conduct

04-12-2014

The Australian Competition and Consumer Commission has granted interim authorization to trade body Medicines…

AustraliaAustralian Competition and Consumer CommissionPharmaceuticalPharmacologyPolitics

Array BioPharma to regain global rights to binimetinib from Novartis

04-12-2014

Shares of US biotech firm Array BioPharma leapt 22.8% to $4.80 in after-hours trading on Wednesday, after…

Array BioPharmabinimetinibBiotechnologyGlobalLicensingNovartisOncology

Added benefit of Lundbeck’s Selincro not proven, says IQWiG

04-12-2014

The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment…

GermanyLundbeckNeurologicalPharmaceuticalPricingRegulationSelincro

ABPI welcomes Chancellor’s decision to increase rate of R&D tax credits

04-12-2014

In his Autumn Statement yesterday, UK Chancellor of the Exchequer, George Osborne said he wants to help…

FinancialPharmaceuticalResearchUK

UK’s BTG buys PneumRx for up to $475 million

04-12-2014

Dutch venture capital firm Forbion Capital Partners has sold its portfolio company PneumRx to UK health…

BTGMergers & AcquisitionsPharmaceuticalPneumRxRespiratory and Pulmonary

EMA committee concludes no evidence Fluad caused deaths

EMA committee concludes no evidence Fluad caused deaths

04-12-2014

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that…

EuropeFluadNovartisPharmaceuticalRegulationVaccines

ADMA’s lead product meets primary endpoint in Phase III trial

04-12-2014

US-based biopharmaceutical company ADMA Biologics says that its lead product candidate RI-002 has demonstrated…

ADMA BiologicsImmunologicalsPharmaceuticalResearchRI-002USA

Age-related macular degeneration treatment market to reach $10 billion by 2023

Age-related macular degeneration treatment market to reach $10 billion by 2023

04-12-2014

The market for treatments of age-related macular degeneration across seven major countries will almost…

AvastinEuropeEyleaFovistaLucentisMarkets & MarketingOphthalmicsPharmaceuticalUSA

US FDA grants earlier approval for Amgen’s Blincyto for rare form of lymphoblastic leukemia

US FDA grants earlier approval for Amgen’s Blincyto for rare form of lymphoblastic leukemia

04-12-2014

Ahead of the anticipated decision date, the US Food and Drug Administration yesterday approved Blincyto…

AmgenBiotechnologyblinatumomabBlincytoOncologyRegulationUSA

226 to 235 of 97252 results

Back to top